Barnes Dennig Private Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Barnes Dennig Private Wealth Management's VRTX Position: Q2 2026 in Review
Barnes Dennig Private Wealth Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 3 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #309.
Barnes Dennig Private Wealth Management first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $112K in Q2 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Barnes Dennig Private Wealth Management held 3 shares of Vertex Pharmaceuticals worth $1.49K as of Q2 2026.
- Barnes Dennig Private Wealth Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Barnes Dennig Private Wealth Management's portfolio in Q2 2026, its #309 holding.
- Barnes Dennig Private Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- Barnes Dennig Private Wealth Management's Vertex Pharmaceuticals position peaked at $112K in Q2 2025.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Barnes Dennig Private Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.